Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1989-11-13
1990-12-11
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
534 10, 252625, A61K 4300, C07F 500
Patent
active
049769502
ABSTRACT:
The invention concerns a method for suppressing bone marrow which comprises administering to a mammal at least one bone marrow suppressing complex of a radionuclide selected from the group consisting of Samarium-153, Gadolinium-159, Holmium-166 and Yttrium-90 and at least one macrocyclic aminophosphonic acid ligand containing the 1,4,7,10-tetraazacyclododecane moiety, or a physiologically acceptable salt thereof. Suitable compositions for use in this method are also provided.
REFERENCES:
patent: 4508625 (1985-04-01), Graham
patent: 4678667 (1987-07-01), Meares et al.
patent: 4853209 (1989-08-01), Kaplan et al.
patent: 4882142 (1989-11-01), Simon et al.
patent: 4898724 (1990-02-01), Simon et al.
Keeling, A. A. et al., "A Bone Seeking Radiotherapeutic Agent," Journal Nucl Medicine, vol. 30, No. 5, May 1989.
Garlich Joseph R.
McMillan Kenneth
Simon Jaime
Wilson David A.
Maples John S.
The Dow Chemical Company
LandOfFree
Bone marrow suppressing agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bone marrow suppressing agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bone marrow suppressing agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-388922